Influence of age on the prognostic value of mid-regional pro-adrenomedullin in the general population

Heart

Volumn 98, Issue 18, 2012, Pages 1348-1353

  Brouwers, Frank P ^a   De Boer, Rudolf A ^a   Van Der Harst, Pim ^a   Struck, Joachim ^b   De Jong, Paul E ^a   De Zeeuw, Dick ^a   Gans, Rijk O ^a   Gansevoort, Ron T ^a   Hillege, Hans L ^a   Van Gilst, Wiek H ^a   Bakker, Stephan J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b THERMO FISHER SCIENTIFIC   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; ALBUMIN; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CHOLESTEROL; CYSTATIN C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RISK ASSESSMENT; SEX DIFFERENCE; STROKE;

ADRENOMEDULLIN; ADULT; AGE FACTORS; AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOASSAY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; RISK ASSESSMENT; RISK FACTORS;

EID: 84865162695     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-302390     Document Type: Article

References (30)

1. Kitamura K, Kangawa K, Kawamoto M, et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993;192:553-60. (Pubitemid 23227359)
2. Sugo S, Minamino N, Kangawa K, et al. Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun 1994;201:1160-6. (Pubitemid 24234212)
3. Eto T. A review of the biological properties and clinical implications of adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP), hypotensive and vasodilating peptides. Peptides 2001;22 :1693-711. (Pubitemid 34062786)
4. Hinson JP, Kapas S, Smith DM. Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 2000;21:138-67. (Pubitemid 32275593)
5. Yanagawa B, Nagaya N. Adrenomedullin: molecular mechanisms and its role in cardiac disease. Amino Acids 2007;32:157-64. (Pubitemid 44866583)
6. Bunton DC, Petrie MC, Hillier C, et al. The clinical relevance of adrenomedullin: a promising profile? Pharmacol Ther 2004;103 :179-201. (Pubitemid 39302634)
7. Dieplinger B, Mueller T, Kollerits B, et al. Pro-A-type natriuretic peptide and proadrenomedullin predict progression of chronic kidney disease: the MMKD study. Kidney Int 2009;75:408-14.
8. Kato J, Tsuruda T, Kita T, et al. Adrenomedullin: a protective factor for blood vessels. Arterioscler Thromb Vasc Biol 2005;25:2480-7. (Pubitemid 43732267)
9. Morgenthaler NG, Struck J, Alonso C, et al. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clin Chem 2005;51:1823-9. (Pubitemid 41368172)
10. Smith JG, Newton-Cheh C, Hedblad B, et al. Distribution and correlates of midregional proadrenomedullin in the general population. Clin Chem 2009;55:1593-5.
11. Staub D, Futterer M, Morgenthaler NG, et al. Use of midregional proadrenomedullin in the detection of myocardial ischaemia. Eur J Clin Invest 2007; 37:83-4. (Pubitemid 44934776)
12. Khan SQ, O'Brien RJ, Struck J, et al. Prognostic value of midregional proadrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study. J Am Coll Cardiol 2007;49:1525-32. (Pubitemid 46517963)
13. Klip IT, Voors AA, Anker SD, et al. Prognostic value of mid-regional proadrenomedullin in patients with heart failure after an acute myocardial infarction. Heart 2011;97 :892-8.
14. Yu CM, Cheung BM, Leung R, et al. Increase in plasma adrenomedullin in patients with heart failure characterised by diastolic dysfunction. Heart 2001;86:155-60. (Pubitemid 32983479)
15. von Haehling S, Filippatos GS, Papassotiriou J, et al. Mid-regional proadrenomedullin as a novel predictor of mortality in patients with chronic heart failure. Eur J Heart Fail 2010;12:484-91.
16. Bhandari SS, Davies JE, Struck J, et al. The midregional portion of proadrenomedullin is an independent predictor of left ventricular mass index in hypertension. Metabolism 2010;59:7-13.
17. Maisel A, Mueller C, Nowak RM, et al. Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol 2011;58:1057-67.
18. Bhandari SS, Davies JE, Struck J, et al. Influence of confounding factors on plasma mid-regional pro-adrenomedullin and mid-regional pro-A-type natriuretic peptide concentrations in healthy individuals. Biomarkers 2011;16:281-7.
19. Diercks GF, van Boven AJ, Hillege HL, et al. Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population. the PREVEND (Prevention of REnal and vascular ENdstage Disease) study. Eur Heart J 2000;21:1922-7.
20. Pinto-Sietsma SJ, Janssen WM, Hillege HL, et al. Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population. J Am Soc Nephrol 2000;11:1882-8.
21. Hillege HL, Fidler V, Diercks GF, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002;106:1777-82.
22. Collinson PO, Barnes SC, Gaze DC, et al. Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers. Eur J Heart Fail 2004;6:365-8. (Pubitemid 38253059)
23. Smilde TD, van Veldhuisen DJ, Navis G, et al. Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction. Circulation 2006;114 :1572-80. (Pubitemid 44547427)
24. D'Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham heart study. Circulation 2008;117:743-53. (Pubitemid 351640675)
25. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47. (Pubitemid 28213628)
26. Statistics Netherlands . http://www.cbs.nl/en-GB/menu/home/default.htm? Languageswitch=on (accessed 26 Apr 2012).
27. Prismant. National LHR information (In Dutch). http://www.prismant.nl (accessed 26 Apr 2012).
28. Linssen GC, Bakker SJ, Voors AA, et al. N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population. Eur Heart J 2010;31:120-7.
29. Lewis LK, Smith MW, Yandle TG, et al. Adrenomedullin(1-52) measured in human plasma by radioimmunoassay: plasma concentration, adsorption, and storage. Clin Chem 1998; 44:571-7. (Pubitemid 28141354)
30. Melander O, Newton-Cheh C, Almgren P, et al. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 2009;302:49-57.